RODI FERTILITY PRODUCTS

RODI Fertility was created to address one of the most persistent gaps in reproductive medicine: women who experience miscarriage, implantation failure, or repeated IVF failure despite “normal” findings. Led by Dr. Barbara Geladakis, RODI pioneered an immune-based approach that reframes fertility care through the lens of reproductive immunology—bringing science, clinical insight, and compassion into one protocol-driven solution.

Being awarded the title of Fertility Solutions Development of the Year 2025 in Europe by Life Science Reviews is a major milestone for RODI and a powerful validation of what we have built: a new, clinically driven approach to fertility support.This recognition reflects the innovation behind RODI NK plus and RODI NK, two products that have helped reshape how clinicians and patients think about fertility care, especially in the most challenging cases: unexplained infertility, recurrent miscarriage, implantation failure, and repeated IVF failure. 

“RODI NK Plus prepares your immune system before conception, while RODI NK supports the first trimester of pregnancy. They balance rather than suppress immune activity. Together, they help normalize NK cell levels prior to conception and promote general healthy immune tolerance to the fetus early in pregnancy. 

An interview by Francesca Veronessi of the Marvex Biovalley Foundation published by Innovando News.